Morgan Stanley »

Outlook Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Outlook Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Outlook Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Outlook Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-03-31 $143k 12k 11.94

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)
Alphabet Cap Stk Cl C (GOOG)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Eli Lilly & Co. (LLY)
Ishares Tr Core S&p500 Etf (IVV)
UnitedHealth (UNH)

View all positions for Morgan Stanley

Top funds holding Outlook Therapeutics

Tang Capital Management
Dr. Jeffrey R. Jay, M.D.
Armistice Capital
Sphera Funds Management
BlackRock
Velan Capital Investment Management
Caligan Partners
Vanguard Group
Schonfeld Strategic Advisors
Geode Capital Management
Northern Trust
Bank of America Corporation
Walleye Trading Advisors
Hrt Financial
Millennium Management

View all funds holding Outlook Therapeutics